Addressing Drug Quality: Aging Facilities

Published on: 

BioPharm International Multimedia

Sue Schniepp, Chair, PDA Regulatory and Quality Advisory Board, and Hal Basemen, Chair, PDA, speak with BioPharm International.

Sue Schniepp, Chair, PDA Regulatory and Quality Advisory Board, and Hal Basemen, Chair, PDA, spoke with BioPharm International about addressing drug quality in aging facilities. 

 

Related Content:

Quality/GMPsBioPharm Videos
Pitfalls in Aging Facilities
Behind the Headlines: GLP-1 Shortage, Nobel Prize, RNA Editing, and More
Discussing Proper Analysis of HCPs in Biomanufacturing (AAPS PharmSci 360)